|
Peter S. Ringrose, Ph.D. joined us as a director in February 2005. Dr. Ringrose's experience in the pharmaceutical industry spans more than 30 years and includes key leadership positions as Senior Vice-President for Worldwide Drug Discovery and Medicinal R & D Europe at Pfizer, Inc. and Division Director of Chemotherapy, Infectious Diseases and Molecular Sciences at the Sandoz Research Institute in Vienna, Austria. In 2002, Dr. Ringrose retired from Bristol-Myers Squibb, where he served as the company's Chief Scientific Officer, as well as President of the Pharmaceutical Research Institute. Dr. Ringrose is currently chair of the Biotechnology and Biological Sciences Research Council (UK). He is a nonexecutive director of Cambridge Antibody Technology and Astex Technology and serves on the scientific advisory board of Cambridge Antibody Technology and Merlin Biosciensces Limited. Dr. Ringrose also serves on the Board of Governors for the New York Academy of Sciences and is a council member of the Foundation for Science and Technology in the United Kingdom. Dr. Ringrose received a BS, an MA and a Ph.D. from the University of Cambridge. | 